BioLife Solutions Inc. (BLFS)
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
BioLife Solutions Inc. (BLFS) was listed on Nasdaq from November 22, 1989 and stopped trading under the symbol BLFS on October 7, 2026.
- Listed On
- Nasdaq
- Listed Since
- November 22, 1989
- Stopped Trading
- October 7, 2026
- Employees
- 155
About BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 206 institutions reported holding BLFS, with 49.2 million shares worth $1.4 billion in aggregate. The largest reported holder was T. Rowe Price, with 6.8 million shares worth $191.9 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| T. Rowe Price | 6,796,848 | $192M | Added 3.82% |
| BlackRock | 6,375,545 | $180M | Added 4.49% |
| Casdin Capital | 4,655,000 | $131M | Reduced 21.86% |
| Vanguard | 3,214,087 | $91M | Added 3.33% |
| Invesco Ltd | 2,240,423 | $63M | Reduced 4.6% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BLFS?
BioLife Solutions Inc. (BLFS) was listed on Nasdaq from November 22, 1989 and stopped trading under the symbol BLFS on October 7, 2026.
Who are the largest institutional holders of BLFS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BLFS were T. Rowe Price, BlackRock and Casdin Capital.
How many institutions own BLFS?
206 institutions reported a position in BLFS for the quarter ended June 30, 2026, worth $1.4 billion in total.
Did institutions buy or sell BLFS last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for BLFS.
Every reported institutional holder, plus insider and congressional trades in BLFS, on SentiSense.